The Preclinical Modelling Portfolio is fighting back against the lack of predictability in preclinical research. We empower scientists with new insights into the development and application of more representative in vitro/in vivo models.
Focused predominantly on the complex modelling of hard to treat conditions in Immuno-Oncology, Fibrotic and Inflammatory Disorders, the events showcase new types of disease models that are under development. Assessing new technologies, data and applications we aspire to help the global biopharma community enhance their translational decision making and ultimately reduce clinical failures rates.
“This conference was amazing! The collaborations I created are priceless. Thanks so much!”
Kiera Rycaj, Assistant Professor, Roswell Park Cancer Institute